The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KRAS mutation as a predictor for cause-specific survival in early- versus late-onset colorectal cancer: A United States population-based study.
 
Albert Y. Lin
No Relationships to Disclose
 
Amanda R Kahl
No Relationships to Disclose
 
Jennifer Y. Pan
No Relationships to Disclose
 
Joshua Lo
No Relationships to Disclose
 
Winifred Tung
No Relationships to Disclose
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Genentech; Ipsen; Merck; Novartis
Consulting or Advisory Role - Genentech/Roche; ipsen; Merck
Research Funding - Aduro Biotech (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Mary E. Charlton
No Relationships to Disclose